Access cutting-edge advanced cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access advanced cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced cancer treatment provided free
This study will evaluate the safety, efficacy, optimal dose, and pharmacokinetics (PK) of BNT326 as monotherapy (Part 1) and as combination treatment with immunotherapeutic agents (Part 2) in participants with histologically or cytologically confirmed solid tumors that are advanced (i.e., either metastatic or recurrent tumors with no further definitive treatment possible) and/or have relapsed/progressed after prior therapy.
Sponsor: BioNTech SE
Check if you qualify for this advanced cancer clinical trial in Boston, MA
If you're searching for advanced cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.